[HTML][HTML] Brazilian guidelines of hypertension–2020

…, SL Amaral, SR Ferreira-Filho, SE Kaiser… - Arquivos brasileiros de …, 2021 - SciELO Brasil
Sergio Emanuel Kaiser Engage, Alecardio, RED-HF, Odissey-Outcomes, SELECT
Amgen, Novo Nordisk, Novartis, astrazeneca, Momenta Farma, Daiichi-Sankyo, Pfizer …

[HTML][HTML] Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer

S Kaiser, YK Park, JL Franklin, RB Halberg, M Yu… - Genome biology, 2007 - Springer
Background The expression of carcino-embryonic antigen by colorectal cancer is an example
of oncogenic activation of embryonic gene expression. Hypothesizing that oncogenesis-…

Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis

…, O Alpan, B Enav, I Hirano, K Nadeau, S Kaiser… - Journal of Allergy and …, 2015 - Elsevier
… Rothenberg MD, PhD a , Ting Wen PhD a , Allison Greenberg BA a b , Oral Alpan MD c ,
Benjamin Enav MD c d , Ikuo Hirano MD e , Kari Nadeau MD, PhD f , Sergio Kaiser PhD g , …

[HTML][HTML] Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019

…, JC Schneider, MHV Assad, SE Kaiser… - Arquivos brasileiros de …, 2019 - SciELO Brasil
Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

S Wonnacott, S Kaiser, A Mogg, L Soliakov… - European journal of …, 2000 - Elsevier
The modulation of striatal dopamine release by presynaptic nicotinic acetylcholine receptors
is well documented for both synaptosomes and slices. Because the latter retain local …

α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H] dopamine release in rat striatal slices via glutamate release

S Kaiser, S Wonnacott - Molecular pharmacology, 2000 - ASPET
Nicotinic agonists elicit the release of dopamine from striatal synaptosomes by acting on
presynaptic nicotinic acetylcholine receptors (nAChRs) on dopamine nerve terminals. Both α3β2…

Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues

…, J Williams, P Ackerman, S Kong, AG Jegga, S Kaiser… - Cancer research, 2006 - AACR
Malignant peripheral nerve sheath tumors (MPNST) are highly invasive soft tissue sarcomas
that arise within the peripheral nerve and frequently metastasize. To identify molecular …

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene

…, T Mehta, A Hardiman, E Sites, S Kaiser… - EMBO molecular …, 2009 - embopress.org
Understanding the biological pathways critical for common neurofibromatosis type 1 (NF1)
peripheral nerve tumours is essential, as there is a lack of tumour biomarkers, prognostic …

UB-165: a novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes

CGV Sharples, S Kaiser, L Soliakov… - Journal of …, 2000 - Soc Neuroscience
Presynaptic nicotinic acetylcholine receptors (nAChRs) on striatal synaptosomes stimulate
dopamine release. Partial inhibition by the α3β2-selective α-conotoxin-MII indicates …

[HTML][HTML] A proteogenomic view of Parkinson's disease causality and heterogeneity

S Kaiser, L Zhang, B Mollenhauer, J Jacob… - npj Parkinson's …, 2023 - nature.com
The pathogenesis and clinical heterogeneity of Parkinson’s disease (PD) have been
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …